Clinical Trial Detail

NCT ID NCT02205515
Title An Open Label, Single-Centre, Phase II Study of Everolimus With EBRT for the Treatment of mNET Liver Metastasis
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Sunnybrook Health Sciences Centre
Indications

neuroendocrine tumor

Therapies

Everolimus

Age Groups: adult

No variant requirements are available.